Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and tolerability of ABVD and Stanford V for elderly advanced-stage Hodgkin lymphoma (HL): Analysis from the phase III randomized US Intergroup Trial E2496 Evens, A. M., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N., Connors, J. M., Wagner, H., Gospodarowicz, M. K., Cheson, B. D., Advani, R., Kahl, B. S., Hoppe, R. T., Horning, S. J. AMER SOC CLINICAL ONCOLOGY. 2011
View details for DOI 10.1200/jco.2011.29.15_suppl.8035
View details for Web of Science ID 000208880302349